Toralf Roch
Overview
Explore the profile of Toralf Roch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1992
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goodman J, Cowan K, Golob M, Nelson R, Baltrukonis D, Bloem K, et al.
Bioanalysis
. 2024 Aug;
16(17-18):905-913.
PMID: 39119660
Immunogenicity regulatory guidance and industry recommendations have evolved over the last two decades since unexpected immune reactions were first reported with erythropoietin. Since then, the guidelines and practices for immunogenicity...
2.
Moradian H, Schwestka M, Roch T, Gossen M
Bioeng Transl Med
. 2024 Jul;
9(4):e10622.
PMID: 39036083
Recent technological advances in the production of in vitro transcribed messenger RNA (IVT-mRNA) facilitate its clinical use as well as its application in basic research. In this regard, numerous chemical...
3.
Blazquez-Navarro A, Roch T, Wehler P, Kaliszczyk S, Bauer C, Thieme C, et al.
Front Transplant
. 2024 Jul;
2:1188535.
PMID: 38993901
Human herpesvirus 6 (HHV-6) is a common opportunistic pathogen in kidney transplant recipients. Two distinct species of HHV-6, HHV-6A and HHV-6B, have been identified, of which the latter seems to...
4.
Rosiewicz K, Blazquez-Navarro A, Kaliszczyk S, Bauer C, Or-Guil M, Viebahn R, et al.
Front Transplant
. 2024 Jul;
3:1393838.
PMID: 38993745
Background: Mono and combined reactivation of latent viruses occurs frequently under immunosuppressive therapy in kidney transplant patients. Recently, monitoring torque teno virus (TTV) reactivation came more into focus as a...
5.
Baudis S, Roch T, Balk M, Wischke C, Lendlein A, Behl M
ACS Biomater Sci Eng
. 2024 Feb;
10(3):1481-1493.
PMID: 38374768
Controlling cellular responses to nanoparticles so far is predominantly empirical, typically requiring multiple rounds of optimization of particulate carriers. In this study, a systematic model-assisted approach should lead to the...
6.
Pellegrino A, Fabig S, Kersebaum D, Hullemann P, Baron R, Roch T, et al.
Biomedicines
. 2023 Mar;
11(3).
PMID: 36979743
Polyneuropathies (PNP) are the most common type of disorder of the peripheral nervous system in adults. However, information on microRNA expression in PNP is lacking. Following microRNA sequencing, we compared...
7.
Roch T, Wehler P, Blazquez-Navarro A, Bachmann F, Neumann I, Kaliszczyk S, et al.
Transplantation
. 2023 Jan;
107(2):e58-e59.
PMID: 36696521
No abstract available.
8.
Heinen N, Marheinecke C, Bessen C, Blazquez-Navarro A, Roch T, Stervbo U, et al.
Front Immunol
. 2023 Jan;
13:1062210.
PMID: 36618413
With the emergence of novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Variants of Concern (VOCs), vaccination studies that elucidate the efficiency and effectiveness of a vaccination campaign are critical to...
9.
Blazquez-Navarro A, Roch T, Wehler P, Stervbo U, Bauer C, Wolk K, et al.
J Nephrol
. 2022 Dec;
36(4):1071-1073.
PMID: 36459372
No abstract available.
10.
Shen P, Rother M, Stervbo U, Lampropoulou V, Calderon-Gomez E, Roch T, et al.
Eur J Immunol
. 2022 Dec;
53(2):e2250059.
PMID: 36458588
Toll-like receptors (TLR) control the activation of dendritic cells that prime CD4 T cells in draining lymph nodes, where these T cells then undergo massive clonal expansion. The mechanisms controlling...